Last reviewed · How we verify

NCT06708715: STRAVA

Stress Reduction After Use of a Haptic Vibrotactile Trigger Technology Patch: Analysis and Assessment

Active, enrolled NA Last updated 8 December 2025
What this trial tests

NA trial testing PEACE Patch in Stress in 150 participants. Participants enrolled and being followed up; not accepting new ones.

Timeline
5 May 2023
Primary endpoint
1 May 2026
1 May 2026

Quick facts

Lead sponsorSuperPatch Limited LLC
PhaseNA
StatusActive, enrolled
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposetreatment
Enrollment150
Start date5 May 2023
Primary completion1 May 2026
Estimated completion1 May 2026
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

SuperPatch Limited LLC

Who can join

Adults 18 to 85, any sex, with Stress or Anxiety. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this research study is to collect subject perceptions or feelings about their treatment. Participation includes a survey from individuals who are receiving a stress or anxiety-relieving topical patch \[Super Patch PEACE Patch with Haptic Vibrotactile Trigger Technology (VTT)\] and assigned to a Treatment Group or given a Sham patch, assigned to the Control Group, to address symptoms or stress and anxiety symptoms using validated scales \[for example, The Perceived Stress Scale (PSS) or Medical Outcomes Study Short Form-20 (SF-20)\].

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Stress

Currently open trials in the same condition.

Other SuperPatch Limited LLC trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06708715.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing